SELLAS Life Sciences (SLS) Gross Margin (2020 - 2022)
Historic Gross Margin for SELLAS Life Sciences (SLS) over the last 3 years, with Q1 2022 value amounting to 90.0%.
- SELLAS Life Sciences' Gross Margin fell 82500.0% to 90.0% in Q1 2022 from the same period last year, while for Dec 2022 it was 90.0%, marking a year-over-year decrease of 73700.0%. This contributed to the annual value of 90.0% for FY2022, which is 73700.0% down from last year.
- According to the latest figures from Q1 2022, SELLAS Life Sciences' Gross Margin is 90.0%, which was down 82500.0% from 94.74% recorded in Q2 2021.
- SELLAS Life Sciences' Gross Margin's 5-year high stood at 100.0% during Q4 2020, with a 5-year trough of 90.0% in Q1 2022.
- In the last 3 years, SELLAS Life Sciences' Gross Margin had a median value of 96.49% in 2021 and averaged 95.75%.
- Examining YoY changes over the last 5 years, SELLAS Life Sciences' Gross Margin showed a top increase of -82500bps in 2022 and a maximum decrease of -82500bps in 2022.
- Quarter analysis of 3 years shows SELLAS Life Sciences' Gross Margin stood at 100.0% in 2020, then fell by -5bps to 94.74% in 2021, then decreased by -5bps to 90.0% in 2022.
- Its Gross Margin stands at 90.0% for Q1 2022, versus 94.74% for Q2 2021 and 98.25% for Q1 2021.